Access to Pharmaceutical Patents in the COVID-19 Emergency: A Case for Government Use in Nigeria
Abstract
The COVID-19 pandemic has continued to exert enormous pressure on public health policies and systems, with far-reaching implications. The race for vaccines has raised important intellectual property rights issues. These are evident in the need to advance the public interest and in the obligation of governments to address the challenge of access to vaccines, especially in sub-Saharan countries like Nigeria with relatively underdeveloped...
Paper Details
Title
Access to Pharmaceutical Patents in the COVID-19 Emergency: A Case for Government Use in Nigeria
Published Date
Oct 12, 2021
Journal
Volume
65
Issue
S2
Pages
259 - 286
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History